Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ASP Isotopes (ASPI) Cost of Revenue (2023 - 2025)

ASP Isotopes has reported Cost of Revenue over the past 3 years, most recently at $14.6 million for Q4 2025.

  • On a quarterly basis, Cost of Revenue rose 2376.8% to $14.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $20.4 million, a 703.3% increase, with the full-year FY2025 number at $20.4 million, up 703.3% from a year prior.
  • Cost of Revenue reached $14.6 million in Q4 2025 per ASPI's latest filing, up from $4.5 million in the prior quarter.
  • The five-year high for Cost of Revenue was $14.6 million in Q4 2025, with the low at $294056.0 in Q4 2023.
  • The 3-year median for Cost of Revenue is $626247.0 (2025), against an average of $2.6 million.
  • The largest YoY upside for Cost of Revenue was 2376.8% in 2025 against a maximum downside of 4.15% in 2025.
  • Tracing ASPI's Cost of Revenue over 3 years: stood at $294056.0 in 2023, then surged by 100.14% to $588527.0 in 2024, then surged by 2376.8% to $14.6 million in 2025.
  • According to Business Quant data, Cost of Revenue over the past three periods came in at $14.6 million, $4.5 million, and $626247.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.